A batch of a multiple sclerosis (MS) medication has been recalled due to a manufacturing issue that affects the dissolution of the capsules. The medication, called Copaxone, is a glatiramer acetate injection used to treat relapsing forms of MS. The recall was initiated by the manufacturer, Teva Pharmaceuticals, after it was discovered that some capsules may not be dissolving at the expected rate.<\/p>\n
The issue was identified during routine testing, which revealed that some capsules were not meeting the required dissolution specifications. As a result, Teva Pharmaceuticals has recalled the affected batch, which was distributed in the UK and other countries. The company has stated that the recall is a precautionary measure to ensure the quality and efficacy of the medication.<\/p>\n
The slow dissolution of the capsules may affect the release of the active ingredient, glatiramer acetate, which could potentially impact the medication’s effectiveness in managing MS symptoms. However, Teva Pharmaceuticals has emphasized that there is no evidence to suggest that the affected batch poses a safety risk to patients.<\/p>\n
Patients who are currently taking Copaxone are advised to check their medication packaging to see if it is part of the recalled batch. The affected batch numbers and expiry dates can be found on the Medicines and Healthcare products Regulatory Agency (MHRA) website. If a patient has a recalled batch, they should contact their pharmacist or healthcare provider for advice on what to do next.<\/p>\n
Teva Pharmaceuticals has assured patients that alternative supplies of Copaxone are available, and that they are working to rectify the issue as quickly as possible. The company has also stated that it is cooperating fully with regulatory authorities to resolve the issue.<\/p>\n
The recall highlights the importance of quality control measures in the pharmaceutical industry. Regular testing and inspection of medications are crucial to ensuring that they meet the required standards of quality, safety, and efficacy. The MHRA has stated that it is monitoring the situation closely and will take further action if necessary to protect public health.<\/p>\n
In the meantime, patients with MS are advised to continue taking their medication as prescribed, unless advised otherwise by their healthcare provider. If patients have any concerns or questions about the recall, they should contact their pharmacist or healthcare provider for guidance and support.<\/p>\n","protected":false},"excerpt":{"rendered":"
A batch of a multiple sclerosis (MS) medication has been recalled due to a manufacturing issue that affects the dissolution of the capsules. The medication, called Copaxone, is a glatiramer acetate injection used to treat relapsing forms of MS. The recall was initiated by the manufacturer, Teva Pharmaceuticals, after it was discovered that some capsules […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-89845","post","type-post","status-publish","format-standard","hentry","category-pharma"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89624,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2025\/12\/06\/fda-announces-voluntary-recall-of-certain-high-blood-pressure-medications-the-hill\/","url_meta":{"origin":89845,"position":0},"title":"FDA announces voluntary recall of certain high-blood pressure medications – The Hill","author":"Team Small News","date":"December 6, 2025","format":false,"excerpt":"The US Food and Drug Administration (FDA) has announced a voluntary recall of certain high-blood pressure medications due to concerns over potential contamination. The recall affects several lots of medications containing the active ingredient valsartan, which is used to treat high blood pressure and heart failure. The FDA has identified\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89646,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2025\/12\/10\/a-widely-used-blood-pressure-medication-has-been-recalled-due-to-concerns-of-potential-contamination-with-a-different-pharmaceutical-compound\/","url_meta":{"origin":89845,"position":1},"title":"A widely used blood pressure medication has been recalled due to concerns of potential contamination with a different pharmaceutical compound.","author":"Team Small News","date":"December 10, 2025","format":false,"excerpt":"Glenmark Pharmaceuticals Inc. has issued a recall of over 11,100 bottles of its blood pressure medication, Ziac, due to potential cross-contamination with another drug. The medication, which is used to treat high blood pressure, also known as hypertension, may contain ezetimibe, a drug used to treat high cholesterol. The recall\u2026","rel":"","context":"In "Glenmark"","block_context":{"text":"Glenmark","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/glenmark\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89791,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/12\/aurobindo-pharma-acquires-khandelwal-labs-non-cancer-portfolio-for-%e2%82%b9325-crore\/","url_meta":{"origin":89845,"position":2},"title":"Aurobindo Pharma Acquires Khandelwal Labs’ Non-Cancer Portfolio for \u20b9325 Crore.","author":"Team Small News","date":"January 12, 2026","format":false,"excerpt":"Aurobindo Pharma, a leading Indian pharmaceutical company, has acquired the non-oncology business of Khandelwal Laboratories for \u20b9325 crore. The acquisition is a strategic move by Aurobindo Pharma to expand its product portfolio and strengthen its position in the domestic market. Khandelwal Laboratories is a Mumbai-based pharmaceutical company that operates in\u2026","rel":"","context":"In "Aurobindo Pharma"","block_context":{"text":"Aurobindo Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/aurobindo-pharma\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89710,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2025\/12\/27\/the-us-fda-has-issued-a-recall-for-an-antifungal-shampoo-manufactured-by-sun-pharma\/","url_meta":{"origin":89845,"position":3},"title":"The US FDA has issued a recall for an antifungal shampoo manufactured by Sun Pharma.","author":"Team Small News","date":"December 27, 2025","format":false,"excerpt":"The US Food and Drug Administration (USFDA) has announced a recall of over 17,000 units of antifungal shampoo, Ciclopirox Shampoo, due to manufacturing issues. The recall was initiated by Taro Pharmaceutical Industries, the US arm of Sun Pharma, on December 9. The shampoo is used to treat seborrheic dermatitis, a\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":89842,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/23\/sun-pharma-receives-dcgi-approval-for-generic-version-of-wegovy-plans-march-release-ahead-of-semaglutide-patent-expiration\/","url_meta":{"origin":89845,"position":4},"title":"Sun Pharma receives DCGI approval for generic version of Wegovy, plans March release ahead of Semaglutide patent expiration.","author":"Team Small News","date":"January 23, 2026","format":false,"excerpt":"Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to launch a generic version of Novo Nordisk's Wegovy, a medication used to treat obesity. The approval comes as the patent for the active ingredient, semaglutide, is set to expire in March 2023. Wegovy, which contains\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":89863,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/26\/glenmark-introduces-emergency-epinephrine-injection-drug-store-news\/","url_meta":{"origin":89845,"position":5},"title":"Glenmark introduces emergency epinephrine injection – Drug Store News","author":"Team Small News","date":"January 26, 2026","format":false,"excerpt":"Glenmark Pharmaceuticals has launched an epinephrine injection, which is the first FDA-approved generic version of Auvi-Q, according to a report by Drug Store News. The epinephrine injection, also known as epinephrine injection, USP, is a prescription medication used to treat life-threatening allergic reactions, including anaphylaxis. The medication is available in\u2026","rel":"","context":"In "Glenmark"","block_context":{"text":"Glenmark","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/glenmark\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89845"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89845\/revisions"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}